Filing Details
- Accession Number:
- 0001127602-10-031328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-21 15:32:44
- Reporting Period:
- 2010-12-17
- Filing Date:
- 2010-12-21
- Accepted Time:
- 2010-12-21 15:32:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226289 | Eric Craig Schneier | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Evp, Hr, Public Affairs & Comm | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-17 | 19,450 | $49.31 | 40,566 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-17 | 19,450 | $68.20 | 21,116 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-17 | 19,450 | $0.00 | 19,450 | $49.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,725 | 2017-02-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 460 | Indirect | By Spouse |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.
Billionaire Hedge Funds
